Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Comi, G, Prof, Pulizzi, A, MD, Rovaris, M, MD, Abramsky, O, Prof, Arbizu, T, MD, Boiko, A, Prof, Gold, R, Prof, Havrdova, E, Prof, Komoly, S, Prof, Selmaj, KW, Prof, Sharrack, B, MD, Filippi, M, MD
Published in The Lancet (British edition) (21.06.2008)
Published in The Lancet (British edition) (21.06.2008)
Get full text
Journal Article